Sormani MP, Häring DA, Kropshofer H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, 277.
Nierfunctie en dementierisico
jan 2017 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen